Micropulse transscleral cyclophotocoagulation effective in I
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Micropulse transscleral cyclophotocoagulation was shown to be effective in reducing IOP in advanced glaucoma patients.

A retrospective chart review of 79 patients showed a reduction in IOP of at least 20% in 78% of cases, with a mean IOP reduction from 31 mm Hg to 17.3 mm Hg, Alice Williams, MD, said at the Wills Eye Conference.Micropulse transscleral cyclophotocoagulation, an alternative to traditional transscleral cyclophotocoagulation, administers a series of laser-delivered pulses followed by a rest period.
“This theoretically allows time for the adjacent tissues to cool and to minimize collateral damage and the complications that are associated with traditional CPC,” Williams said.

Wills Eye Institute is one of the first institutions to use the technology, and the review looked at one surgeon’s experience with it. In the first 3 months after treatment, patients saw an 80% success rate, which decreased to 78% at final follow-up visits, typically 7.5 months after treatment. In addition to a mean reduction in IOP of 15 mm Hg, most patients also experienced a reduction in medications, Williams said. However, there were some notable complications observed.

https://goo.gl/qBUp0k
Preview
Like
Comment
Share